Hypothesis

Mitochondrial RNA:DNA hybrids (R-loops) generated from mutant mtDNA transcripts act as the primary danger signal that triggers cGAS-STING-mediated senescence, rather than free mtDNA fragments alone.

Mechanistic Rationale

• mtDNA heteroplasmy increases the likelihood of aberrant transcription, producing RNAs that anneal to the underlying template and form R-loops, especially at sites of replication stressmtDNA heteroplasmy increases....
• These hybrids are exported through VDAC-dependent channels into the cytosol, where their double-stranded RNA:DNA structure is sensed by cGAS as a non‑canonical ligand, leading to STING activation and the senescence-associated secretory phenotype (SASP)cGAS senses RNA:DNA hybrids....
• Because R-loop formation depends on both mutation load and transcriptional activity, a threshold effect explains why some cells with high heteroplasmy remain senescent‑free while others with lower loads undergo premature senescencethreshold effect....

Novel Insight

Targeting mitochondrial RNA processing—specifically boosting mitochondrial RNase H2 activity to degrade the RNA strand of R-loops—should uncouple mutational burden from inflammatory signaling, preserving mitochondrial function while suppressing senescenceRNase H2 suppresses R-loops....

Testable Predictions

1. In cybrid lines carrying defined levels of pathogenic mtDNA mutations, overexpression of mitochondria-targeted RNase H2 will reduce cytosolic R-loop accumulation (measured by S9.6 immunofluorescence) without altering overall heteroplasmy.
2. Correspondingly, cGAS phosphorylation, STING translocation, and downstream IFN‑β signaling will be attenuated, and SASP cytokines (IL‑6, IL‑8) will drop to baseline levels.
3. Conversely, knockdown of RNase H2 will exacerbate SASP even at low heteroplasmy, confirming the causal role of R-loops.
4. Pharmacological inhibition of VDAC will block the export step, reproducing the protective effect of RNase H2 overexpression, indicating that cytosolic access is required.

Experimental Design (brief)

• Generate ρ0 cells repopulated with mtDNA carrying the m.3243A>G mutation at 0%, 20%, 60%, and 90% heteroplasmy.
• Transduce with mito-RNase H2 or control vector; include a VDAC-blocking compound (e.g., DIDS) arm.
• Assay: dot‑blot for mtDNA, S9.6 staining for R-loops, western blot for p‑cGAS/p‑STING, ELISA for SASP cytokines, Seahorse for respiratory capacity.
• Expected outcome: RNase H2 overexpression reduces R‑loops and SASP proportionally to heteroplasmy, while respiration remains unchanged.

Falsifiability

If mito-RNase H2 overexpression fails to lower cytosolic R-loops or SASP despite efficient expression, or if SASP reduction correlates strictly with decreased mtDNA copy number rather than R‑loop levels, the hypothesis is refuted.